CCMCL1: a new model of aggressive mantle cell lymphoma.
作者信息
Zhao Xiaoxian, Chen-Kiang Selina, Shetty Shashirekha, Di Liberto Maurizio, Bodo Juraj, Durkin Lisa, Eng Ken, Elemento Olivier, Smith Mitchell R, Hsi Eric D
机构信息
Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
Department of Pathology and Laboratory Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College, New York, NY.
出版信息
Blood. 2015 Apr 23;125(17):2730-2. doi: 10.1182/blood-2015-01-622795.
Abstract
摘要
相似文献
1
CCMCL1: a new model of aggressive mantle cell lymphoma.CCMCL1：侵袭性套细胞淋巴瘤的一种新模型。
Blood. 2015 Apr 23;125(17):2730-2. doi: 10.1182/blood-2015-01-622795.
2
Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma.利妥昔单抗和硼替佐米治疗复发或难治性套细胞和滤泡性淋巴瘤患者的 2 期临床试验。
Cancer. 2011 Jun 1;117(11):2442-51. doi: 10.1002/cncr.25792. Epub 2010 Dec 14.
3
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.苯达莫司汀、硼替佐米和利妥昔单抗联合治疗复发/难治性惰性和套细胞非霍奇金淋巴瘤患者。
Blood. 2011 Mar 10;117(10):2807-12. doi: 10.1182/blood-2010-11-314708. Epub 2011 Jan 14.
4
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.硼替佐米联合 CHOP-利妥昔单抗方案治疗初治弥漫性大 B 细胞淋巴瘤和套细胞淋巴瘤。
J Clin Oncol. 2011 Feb 20;29(6):690-7. doi: 10.1200/JCO.2010.31.1142. Epub 2010 Dec 28.
5
Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma.硼替佐米联合利妥昔单抗和地塞米松是复发和化疗耐药套细胞淋巴瘤患者的有效治疗方案。
Haematologica. 2011 Jul;96(7):1008-14. doi: 10.3324/haematol.2011.041392. Epub 2011 Apr 12.
6
Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.利妥昔单抗、硼替佐米、供体淋巴细胞和聚乙二醇化干扰素治疗异基因造血干细胞移植后第三次复发的套细胞淋巴瘤的持久缓解
Clin Lymphoma Myeloma Leuk. 2013 Dec;13(6):e1-5. doi: 10.1016/j.clml.2013.05.006. Epub 2013 Aug 30.
7
Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma.蛋白酶体抑制剂硼替佐米与阿糖胞苷在套细胞淋巴瘤中的序列依赖性协同作用
Leukemia. 2007 Mar;21(3):524-8. doi: 10.1038/sj.leu.2404511. Epub 2007 Feb 1.
8
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.硼替佐米和利妥昔单抗联合治疗通过影响多条生存和死亡通路促进套细胞淋巴瘤细胞凋亡。
MAbs. 2009 Jan-Feb;1(1):31-40. doi: 10.4161/mabs.1.1.7472.
9
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.硼替佐米联合 R-CHOP 方案治疗初治侵袭性非霍奇金淋巴瘤的Ⅰ期临床试验。
Cancer. 2010 Dec 1;116(23):5432-9. doi: 10.1002/cncr.25509. Epub 2010 Jul 27.
10
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo.硼替佐米与利妥昔单抗及环磷酰胺在体外和体内诱导套细胞淋巴瘤细胞凋亡方面具有协同作用。
Leukemia. 2008 Jan;22(1):179-85. doi: 10.1038/sj.leu.2404959. Epub 2007 Sep 27.
引用本文的文献
1
Resistance to PRMT5-targeted therapy in mantle cell lymphoma.套细胞淋巴瘤中对 PRMT5 靶向治疗的耐药性。
Blood Adv. 2024 Jan 9;8(1):150-163. doi: 10.1182/bloodadvances.2023010554.
2
A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.FOXO1 依赖性转录网络是套细胞淋巴瘤的一个可靶向弱点。
J Clin Invest. 2022 Dec 15;132(24):e160767. doi: 10.1172/JCI160767.
3
Inhibition of cyclin-dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphoma.细胞周期蛋白依赖性激酶9的抑制协同增强维奈托克在套细胞淋巴瘤中的活性。
EJHaem. 2020 Aug 4;1(1):161-169. doi: 10.1002/jha2.48. eCollection 2020 Jul.
4
Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells.套细胞淋巴瘤细胞中基因突变异质性的动态变化及核心突变的保留
Front Oncol. 2019 Jul 3;9:568. doi: 10.3389/fonc.2019.00568. eCollection 2019.
5
PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.PRMT5选择性抑制剂可抑制炎症性T细胞反应及实验性自身免疫性脑脊髓炎。
J Immunol. 2017 Feb 15;198(4):1439-1451. doi: 10.4049/jimmunol.1601702. Epub 2017 Jan 13.
本文引用的文献
1
Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection.美国模式培养物集存库中套细胞淋巴瘤细胞库的建立与特性分析
Leuk Lymphoma. 2015 Jul;56(7):2114-22. doi: 10.3109/10428194.2014.970548. Epub 2015 Feb 11.
2
Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways.依鲁替尼与ABT-199联合使用：通过干扰BTK、AKT和BCL2信号通路对套细胞淋巴瘤细胞的增殖抑制和凋亡产生协同作用。
Br J Haematol. 2015 Mar;168(5):765-8. doi: 10.1111/bjh.13149. Epub 2014 Oct 4.
3
Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma.针对PI3K抑制的细胞周期重编程克服了套细胞淋巴瘤纵向功能基因组学揭示的复发特异性C481S BTK突变。
Cancer Discov. 2014 Sep;4(9):1022-35. doi: 10.1158/2159-8290.CD-14-0098. Epub 2014 Jul 31.
4
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.套细胞淋巴瘤中的体细胞突变和克隆进化景观。
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18250-5. doi: 10.1073/pnas.1314608110. Epub 2013 Oct 21.
5
Therapies for mantle cell lymphoma: current challenges and a brighter future.套细胞淋巴瘤的治疗：当前挑战与光明未来
Discov Med. 2013 Mar;15(82):177-87.
6
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.E3 泛素连接酶 UBR5 在套细胞淋巴瘤中经常发生突变。
Blood. 2013 Apr 18;121(16):3161-4. doi: 10.1182/blood-2013-01-478834. Epub 2013 Feb 13.
7
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.共济失调毛细血管扩张症突变基因（ATM）和p53的突变及基因组缺失状态在外套细胞淋巴瘤中赋予特定的基因表达谱。
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2352-7. doi: 10.1073/pnas.0510441103. Epub 2006 Feb 3.
8
Establishment of the MAVER-1 cell line, a model for leukemic and aggressive mantle cell lymphoma.MAVER-1细胞系的建立，一种白血病性侵袭性套细胞淋巴瘤模型。
Haematologica. 2006 Jan;91(1):40-7.
9
Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features.伴有8q24染色体异常的套细胞淋巴瘤：5例母细胞样特征病例报告
Mod Pathol. 2002 Dec;15(12):1266-72. doi: 10.1097/01.MP.0000037310.82136.99.
10
Establishment and characterization of a new mantle cell lymphoma cell line, Mino.一种新的套细胞淋巴瘤细胞系Mino的建立与鉴定
Leuk Res. 2002 Sep;26(9):849-55. doi: 10.1016/s0145-2126(02)00013-9.
Zotero 插件